ページの先頭です。 メニューを飛ばして本文へ
トップページ > Kurume University > Research Centers and Institute > Medical and Nursing > Research Center for Innovative Cancer Therapy

Research Center for Innovative Cancer Therapy

Northern Kyushu has one of the highest rates of cancer incidence and mortality in Japan, and the cancer population in this area is forecast to increase as society continues to age. Under these circumstances, Kurume University has made cancer control the primary focus of its clinical and basic research activities, and The Research Center for Innovative Cancer Therapy has become the central core of cancer research at this Institution.

Our Center was established in fiscal 1996, when the Ministry of Education, Culture, Sports, Science and Technology in Japan(MEXT) set up a grant support program for the establishment of high-tech research centers at private universities . Over the years this program has supported many different research projects at our Center. Currently we have three divisions: Cancer Vaccine Development, Liver Cancer Research, and Molecular Targeting Therapeutics. Some of the major research projects currently underway at the Research Center for Innovative Cancer Therapy are as follows:
 1. Cancer vaccine development project: Basic and clinical research of cancer vaccines and cancer immunotherapy are being conducted by the Cancer Vaccine Development Division in collaboration with the Cancer Vaccine Center at the Medical Center. Many other clinical departments at the School of Medicine are also contributing to the project.
 2. Liver cancer project: Development of innovative diagnostic markers for occurrence and metastasis of liver cancer and novel therapeutic strategies against tumors are being conducted by the Liver Cancer Research Division in collaboration with the Department of Internal Medicine and the Department of Pathology at the School of Medicine.
 3. Molecular targeting project: Basic and clinical research to develop molecular targeting therapy are being conducted by the Molecular Targeting Therapeutics Division. Many clinical departments at the School of Medicine are contributing to the project.

 Development of innovative cancer therapies has always been our primary mission, and we pledge to continue our efforts to insure the rapid delivery of these therapies to cancer patients.

photo photo